,,,,,, NCDR PVI Registry (Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT A. DE...
6 downloads 0 Views 527KB Size
NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT A. DEMOGRAPHICS

First Name2010:

Last Name2000: SSN2030:

-

Birth Date2050:

Race:

(check all that apply)

□ SSN N/A2031

-

Middle Name 2020:

Patient ID2040:

Other ID2045:

(auto)



Patient Zip Code3005:

Sex2060: O Male O Female

mm / dd / yyyy

Zip Code N/A3006

□ White2070 □ Black/African American2071 □ American Indian/Alaskan Native2073 □ Asian2072  If Yes, □ Asian - Indian2080 □ Chinese2081 □ Filipino2082 □ Japanese2083 □ Korean2084 □ Vietnamese2085 □ Other2086 □ Native Hawaiian/Pacific Islander2074  If Yes, □ Native Hawaiian2090 □ Guamanian or Chamorro2091 □ Samoan2092 □ Other Island2093

Hispanic or Latino Ethnicity2076 : O No

 If Yes, Ethnicity Type: (Select all that apply)

O Yes

□ Mexican, Mexican-American, Chicano

2100

□ Puerto Rican2101

□ Cuban2102

□ Other Hispanic, Latino or Spanish Origin2103

B. EPISODE OF CARE

Arrival Date/Time3000/3001:

mm / dd / yyyy HH:MM

Admitting Provider Name, NPI 3050,3051,3052,3053: Attending Provider Name, NPI

3055,3056,3057,3058

:

_______,__,___________________,______________ _______,__,___________________,______________

O No O Yes Health Insurance3005: N674  If Yes, Payment Source : (Select all that apply)

□ Private Health Insurance □ State-Specific Plan (non-Medicaid)

□ Medicare □ Medicaid □ Military Health Care □ Indian Health Service □ Non-US Insurance

HIC # 3030: Research Study3035:

O No

□ Patient RestrictionN683

O Yes

 If Yes, Study Name3036, Patient ID3037:

_______________, _________

C. HISTORY (LEADING TO EPISODE OF CARE)

Hypertension4000: Dyslipidemia

O No

4005

:

Coronary Artery Disease4025: 4065

Prior Myocardial Infarction

:

 If Yes, Within 30 Days4070: PCI 4090: CABG 4095: Heart Failure4080:

O Yes

O No

O Yes

O No

O Yes

O No

O Yes

O No

O Yes

O No O No

O Yes O Yes

O No

O Yes

5210

If Yes, NYHA Class w/in 2 weeks O Class III O Class I O Class II

O Yes

LV Systolic Dysfunction108:

O No

O Yes

O No _______%

O Yes

O No

O Yes

O No

O Yes

O No

O Yes

Chronic Kidney Disease :  If Yes,Currently On Dialysis 4020:

O No

O Yes

O No

O Yes

Chronic Lung Disease4060:

O No

O Yes

4100

Prior Valve Surgery/Procedure

Prior History of Arrhythmia

:

109

Positive Cardiac Stress Test C112

:

C114

:

cm

Weight4120:

_______

4010

O No

Diabetes Mellitus :  If Yes, Diabetes Therapy C120: □ None □ Diet □ Oral Anginal Classification w/in 2 Weeks

Cerebrovascular Disease

O No

If Yes, Pre-Procedure LVEF 5700:

_______

5205

:

Hemorrhagic Stroke

O Yes

O No symptoms O CCSI O CCSII O CCSIII O CCSIV

4040

Stroke4041: Nxxx

kg

□ Insulin □ Other

Peripheral Artery Disease History 4050:

: O Class IV

Cardiomyopathy107:

Pre-Procedure LVEF Assessed 5701:

Height 4115:

:

O No

O Yes

O No

O Yes

O No

O Yes

O No

O Yes

Tobacco Use 4105: O Current - Some Days O Never O Current, Frequency Unknown O Former O Current, Every Day If any Current, Tobacco Type4626 (select all that apply) □ Cigarettes □ Cigars □ Pipe □ Smokeless If Current - Every Day and Cigarettes, Amount O Light tobacco use (< 10/day) O Heavy tobacco use (>= 10/day)

4627

Page 1 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module - DRAFT C. HISTORY (LEADING TO EPISODE OF CARE, CONTINUED)

Neck Radiation4125:

O No 4130

Neck Surgery (other than CEA)

: 4145:

Previous Carotid Revascularization

O No

O Yes

O No

O Yes

 If Yes, Type/Side:

Tracheostomy Present4135:

O Yes

Laryngeal Nerve Palsy

4140

:

Right

Carotid Artery Stent4150,4170:

O No

O Yes

O No

O Yes - Right O Yes - Left O Yes - Bilateral

Left

4155 O No O Yes  If Yes, Date : mm / dd / yyyy O No O Yes

 If Yes, Date 4175: mm / dd / yyyy

Carotid Endarterectomy4160,4180: O No O Yes  If Yes, Date4165: mm / dd / yyyy O No O Yes

 If Yes, Date 4185: mm / dd / yyyy

Carotid PTA 113, 115:

O No O Yes  If Yes, Date

114

:

mm / dd / yyyy

O No O Yes

 If Yes, Date

116

: mm / dd / yyyy

CVD Presentation5200: O Asymptomatic O Acute evolving stroke

O TIA O Ischemic Stroke

O IC Hemorrhage or Hemorrhagic Stroke 5200

, TimeframeN684:

 If yes to any CVD

O ≤ 60 days O ≥ 60 days to 180 days O ≥ 180 days D. PRESENTATION AND EVALUATION (COMPLETE FOR EACH PROCEDURE. LEADING TO THE PROCEDURE)

Ambulation Status

158

:

O No functional limitations O Ambulates with assistive devices

Pre-Admission Living 159: O Home Independent O Home with Caregiver CSHA Clinical Frailty Score

1 160

:

O Wheelchair/stretcher bound

O Skilled Nursing Facility

O 1 = Very Fit O 2 = Well O 3 = Well, with treated comorbid disease O 4 = Apparently Vulnerable O 5 = Mildly Frail

O Homeless

O Other

O 6 = Moderately Frail O 7 = Severely Frail O 8 = Very Severely Frail O 9 = Terminally Ill

PRE-PROCEDURE ASSESSMENT (COMPLETE FOR EACH PROCEDURE TYPE, ONLY FOR SIDE(S) AFFECTED)

RIGHT Duplex Ultrasound Performed 5360,5560:

O No

O Yes

O No O Yes _________cm/sec

5365,5565

:

_________cm/sec

5370,5570

:

_________cm/sec

_________cm/sec

_________

_________

 If Yes, Peak Systolic Velocity

 If Yes, End Diastolic Velocity  If Yes, ICA/CCA Ratio

LEFT

5375,5575

:

O No O Yes _________ %

O No O Yes _________ %

:

_________ %

_________ %

5430,5630

O No O Yes _________ %

O No O Yes _________ %

 If Yes, ICA Max % Stenosis 5435,5635:

_________ %

_________ %

CT Angiography Performed

5395,5595

:

 If Yes, CCA Max % Stenosis  If Yes, ICA Max % Stenosis

5400,5600

:

5405,5605

MR Angiography Performed 5425,5625:  If Yes, CCA Max % Stenosis

:

NIH Stroke Scale Total Score 5710: _______

Modified Rankin Score5705: O 0: No symptoms at all O 3: Moderate disability O 1: No sig disability despite symptoms O 4: Mod severe disability O 2: Slight disability O 5: Severe disability

Date Administered5706: mm / dd / yyyy

□ Not Administered5707

Date Administered5711:

mm / dd / yyyy

□ Not Administered 5712

Examiner Name 5715,5720,5725: Certified 5730:

O No

O Yes

1

Canadian Study of Health and Aging Clinical Frailty Scale is Used with Permission For The American College of Cardiology Foundation By Dr. Kenneth Rockwood (© Kenneth Rockwood, MD)

Page 2 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT I. PRE-PROCEDURE MEDICATIONS (ADMINISTERED WITHIN 24 HOURS PRIOR TO THE PROCEDURE, COMPLETE FOR EACH PROCEDURE TYPE) 7800

MEDICATION

ADMINISTERED

DOSAGE961

7805

Direct Thrombin Inhibitors P2Y12 Antagonists

Thrombolytics

Thrombin Receptor Antagonist

Antiplatelets

VitK Ant

Direct Factor Xa Inhibitors

Anticoagulants

Heparin and Derivatives

Low

ACE-I

Other

PCSK9 Inhibitor PDE Inhibitor

High

Fondaparinux

O No

O Yes

Low Molecular Wt Heparin

O No

O Yes

Unfractionated Heparin

O No

O Yes

Heparin / Derivative (Other)

O No

O Yes

Argatroban

O No

O Yes

Bivalirudin

O No

O Yes

Dabigatran

O No

O Yes

Apixaban

O No

O Yes

Edoxoban

O No

O Yes

Rivaroxaban

O No

O Yes

Direct Factor Xa Inhibitors (Other)

O No

O Yes

Warfarin

O No

O Yes

Aspirin

O No

O Yes

Dipyridamole

O No

O Yes

Glycoprotein IIb/IIIa Inhibitor (Any)

O No

O Yes

Clopidogrel

O No

O Yes

O No

O YesN717

Prasugrel

O No

O Yes

O No

O YesN718

Ticagrelor

O No

O Yes

O No

O YesN719

Vorapaxar

O No

O Yes

Alteplase

O No

O Yes

Reteplase

O No

O Yes

Streptokinase

O No

O Yes

Tenecteplase

O No

O Yes

Thrombolytic (Other)

O No

O Yes

ACE-Inhibitor (Any)

O No

O Yes

ARB (Any)

O No

O Yes

Valsartan/Sacubitril

O No

O Yes

Beta Blockers (Any)

O No

O Yes

Calcium Channel Blockers (Any)

O No

O Yes

Diuretics (Any)

O No

O Yes

Vasodilators (Any)

O No

O Yes

Statin (Any)

O No

O Yes

O No

O YesN698

Alirocumab

O No

O Yes

Evolocumab

O No

O Yes

PCSK9 Inhibitors (any)

O No

O Yes

Phosphodiesterase Inhibitor (Any)

O No

O Yes

ARB

Sta tin

Moderate

Loading Dose Administered Pre-Procedure

O

O

O

Page 3 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT E. PROCEDURE (COMPLETE FOR EACH PROCEDURE TYPE)

Procedure Start Date/Time6000/6001:

Procedure End Date/Time6005/6006:

mm / dd / yyyy / hh:mm

Operator Name6015, 6020, 6025: Operator Assistant Name

Procedure Type6010:

Operator NPI

N685, N686, N687

O Carotid Artery Stent : O Elective

:

Operator Assistant NPIN688:

:

6035

Procedure Status

mm / dd / yyyy / hh:mm

(break scrub at end of case) 6030

O Carotid Endarterectomy

O Urgent

O Carotid Percutaneous Transluminal Angioplasty

O Emergency

O Cath Lab O IR O OR O Hybrid O Free-standing clinic Location of Procedure 6038 : 6041 O Urgent Cardiac Surgery w/in 30 days Procedure Indication : O Asymptomatic O Restenosis in Target Vessel, prior CEA O Spontaneous Carotid Artery Dissection O Restenosis in Target Vessel, prior CAS O Symptomatic Lesion w/in 6 months Sedation 6050:

O No Sedation O Minimal Sedation/Anxiolysis O Moderate Sedation/Analgesia (Conscious Sedation)

O Deep Sedation/Analgesia O General Anesthesia

Blood Pressure303, 304: (lowest during procedure) _______ / _______ mmHg Blood Pressure

Heart Rate 307: (lowest during procedure) _______ bpm

305, 306

□ Alcohol □ Iodine □ Chlorhexidine

Skin Prep309: (select all that apply) Target Vessel6045:

Heart Rate 308: (highest during procedure) _______ bpm

: (highest during procedure) _______ / _______ mmHg

O Right Carotid O Left Carotid

Contralateral Carotid Artery Occlusion 6070:

Fibromuscular Dysplasia of Carotid Artery Peri-Operative Antibiotic Indicated

O No

O Yes

: O No

O Yes

6075

N450

:

O No

 If Yes, Administered within 1 hour of incision st

 If Yes, Antibiotic 1 or 2

nd

312

: 314

Generation Cephalosporin

:

 If Yes, Antibiotic discontinued within 24 hours of procedure Intra-Procedure Vasopressor AgentsN689: Intra-Procedure Atropine

O No

N690

:

O No

N691

Intra-Procedure NTG

:

O No

313

:

O Yes

O Yes

O No – No Reason

O No – Medical Reason

O Yes

O No – No Reason

O No – Medical Reason

O Yes

O No – No Reason

O No – Medical Reason

O Yes

Intra-Procedure Thrombolytics N451:

O No

O Yes

O Yes

Intra-Procedure AnticoagulantsN180 :

O No

O Yes

O No

O Yes

O No

O Yes

 If Yes, Heparin

O Yes

N181

:

 If Yes,Direct Thrombin Inhibitor

E107

:

ARTERIAL ACCESS (COMPLETE FOR EACH CAS. CODE IN THE ORDER ATTEMPTED.)

Site(s)6200 1

2

Side6205

Vessel6211

O Right O Left

O Femoral O Radial O Brachial/Axillary

O Carotid O Other

O Right O Left

O Femoral O Radial O Brachial/Axillary

O Carotid O Other

Closure Method(s)6220,25,30

□ Not Documented

□ Not Documented

UDI6235-6245

1

(future)

2

(future)

1

(future)

2

(future)

BEST (VISUAL) ESTIMATE OF VASCULAR ANATOMY (COMPLETE FOR EACH CAS. CODE MOST SEVERE LESION IN EACH VESSEL.) Aortic Arch Type6250: O Type I Bovine Arch N692:

O No

O Type II

O Type III

O Not Documented

O Yes Right – Max Stenosis

Native Vessel

_________%

□ CTO

Internal Carotid:

_________%6335

□ CTO6336 □ Not Available6337

_________%6435

□ CTO6436 □ Not Available6437

Vertebral:

_________%6340

□ CTO6341 □ Not Available6342

_________%6440

□ CTO6441 □ Not Available6442

6331

□ Not Available

Left – Max Stenosis

Common Carotid:

6330

6332

6430

_________%

□ CTO6431 □ Not Available6432

Page 4 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT G. CAROTID STENT AND PTA PROCEDURE (COMPLETE FOR EACH CAROTID PROCEDURE ATTEMPTED OR PERFORMED)

Lesion Counter 7300:

1

Lesion Location7305:

O Isolated CCA O Isolated ICA

Lesion Difficult to Access Surgically7310: 7315

 If Yes, Lesion Location

:

Thrombus Present7320:

Ulceration

7325

:

O No

2

O Bifurcation

O Isolated CCA O Isolated ICA

O Yes

O No

O Yes

O High Cervical (C2 or higher) O Low Intrathoracic (below clavicle)

O High Cervical (C2 or higher) O Low Intrathoracic (below clavicle)

O No

O Yes

O No

O Yes

O No

O Yes

O No

O Yes

Calcification7330:

O None O Dense

Lesion Length7335:

_______mm

Stenosis Immediately Prior to Rx7350:

_______%

Embolic Protection Attempted7355:

O No

O Yes

O No

O Yes

 If Yes, Pre-dilation Prior to EPD Deployment7360:

O No

O Yes

O No

O Yes

 If Yes, Pre-dilation Prior to Attempted Stent Implant7365 (after Embolic Protection Device):

O No

O Yes

O No

O Yes

 If Yes, Total Filter/Total Reversal TimeN693:

O Bifurcation

O Mild to Moderate O Concentric

O None O Dense

O Mild to Moderate O Concentric

_______mm

(use NASCET technique unless CCA)

_______minutes

_______%

_______minutes

Post-dilation Performed7370: Procedure Treatment Incomplete or Aborted7375:  If Yes, Reason(s) Procedure Treatment AbortedN694: (Select all that apply) □ Failure to gain vascular access □ Hypotension □ Hypertension □ Arrhythmia □ Cardiac ischemia □ Other

O No

O Yes

O No

O Yes

O No

O Yes

O No

O Yes

Lesion Treatment Incomplete or Aborted N695:  If Yes, Reason(s) Lesion Treatment AbortedN696: (Select all that apply)

O No

O Yes

O No

O Yes

Post-Procedure Final Stenosis 7400:

________%

□ □ □ □ □ □ □ □ □

(use NASCET technique unless CCA)

Failure to confirm significant stenosis Unable to deploy EPD Unable to place guide catheter / sheath Unable to deliver stent Unable to deploy stent Difficult to access due to tortuosity Unable to cross guidewire Unable to cross balloon Other

□ □ □ □ □ □ □ □ □

Failure to confirm significant stenosis Unable to deploy EPD Unable to place guide catheter / sheath Unable to deliver stent Unable to deploy stent Difficult to access due to tortuosity Unable to cross guidewire Unable to cross balloon Other

O Not documentedN697 ________%

(use NASCET technique unless CCA)

O Not documented

(use NASCET technique unless CCA)

LIST ALL DEVICES IN CHRONOLOGICAL ORDER: Device(s) Used7410,7415 1 2 3

Associated Lesion(s)7420 (Specify Lesion Counter, Seq. 7300)

Device Activated7425

UDI7430-7440

______ , ______, ______

O No

O Yes

(future)

______ , ______, ______

O No

O Yes

(future)

______ , ______, ______

O No

O Yes

(future) Page 5 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT H. CAROTID ENDARTERECTOMY PROCEDURE (COMPLETE FOR EACH CAROTID ENDARTERECTOMY ATTEMPTED OR PERFORMED)

Arteriotomy Patch Used7600: 7605

Thrombus Present

O No

(on direct visual inspection):

Shunt Used7610:

O No 7615

Surgical Procedure Terminated

O No

O No

O Yes

O Yes

O Yes

 If Yes, Reason(s) for Termination of Surgery:N714 (Select all that apply) □ Hypotension □ Cardiac instability □ Difficulty with anesthesia □ Inability to implement shunting □ Difficult dissection □ Excessive bleeding □ ICA string sign / atresia □ Inability to access lesion due to anatomy □ Other

: O No

□ Hypertension □ Nerve compromise □ Excessive scar tissue □ Carotid artery thrombosis

Concomitant CABGN713:

O Yes

O Yes

J. PROCEDURE TOTALS (COMPLETE FOR EACH CAS) Contrast Volume8000: Cumulative Air Kerma

Dose Area Product

Fluoro Time8005:

_______ mL 900

:

901

:

_______ minutes

N456

________ O mGy

O Gy

CO2 Used

________ O Gy-cm2

O dGy-cm2

O cGy-cm2

:

O No

O Yes

O mGy-cm2

O µGy-M2

K. LABS (COMPLETE FOR EACH PROCEDURE TYPE) Pre-Procedure / Baseline Creatinine8100:

Post-Procedure (post-procedure only)

□ Not Drawn8105

________mg/dL

Creatinine8130:

________mg/dL

8101/8102

mm/dd/yyyy / hh:mm 8110

Hemoglobin

:

□ Not Drawn

________g/dL

8115

Hemoglobin

8111/8112

mm/dd/yyyy / hh:mm HbA1c 902:

8140

:

(lowest value w/in 72 hrs)

□ Not Drawn8135

mm/dd/yyyy / hh:mm8131/8132 ________g/dL □ Not Drawn8145 mm/dd/yyyy / hh:mm8141/8142

□ Not Drawn 905

________%

903, 904

mm/dd/yyyy / hh:mm

□ Not Drawn8125 ________mg/dL 413 8121/8122 mm/dd/yyyy / hh:mm

LDL:

L. POST-PROCEDURE ASSESSMENT (COMPLETE FOR EACH PROCEDURE, ONLY FOR THE TARGET VESSEL SIDE(S) AFFECTED) Modified Rankin Score8260:

NIH Stroke Scale Total Score8265: _______

O 0: No symptoms at all O 3: Moderate disability O 1: No sig disability despite symptoms O 4: Mod severe disability O 2: Slight disability O 5: Severe disability O 6: Death

Date Administered8261: mm / dd / yyyy

Date Administered8266:

□ Not Administered 8262

mm / dd / yyyy

Examiner Name8270,8275,8280: O No Certified8285:

□ Not Administered 8267

O Yes

M. INTRA OR POST-PROCEDURE EVENTS (COMPLETE FOR EACH PROCEDURE TYPE)

Event

Event Occurred

Event Date(s)

CARDIOVASCULAR Myocardial Infarction8400:

O No

O Yes

mm/dd/yyyy / hh:mm704

Cardiac Arrest705:

O No

O Yes

mm/dd/yyyy / hh:mm706

Heart Failure 8410:

O No

O Yes

mm/dd/yyyy / hh:mm710

New Arrhythmia Requiring Treatment8420:

O No

O Yes

mm/dd/yyyy / hh:mm708

O No

O Yes

Unexpected Intubation 721:

O No

O Yes

mm/dd/yyyy / hh:mm722

Pneumonia723:

O No

O Yes

mm/dd/yyyy / hh:mm724

PULMONARY

mm / dd / yyyy

Page 6 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT M. INTRA OR POST-PROCEDURE EVENTS (COMPLETE FOR EACH PROCEDURE TYPE) ( CONTINUED)

Event

Event Occurred

Event Date(s)

NEUROLOGIC Cranial Nerve InjuryN699:

O No

O Yes

mm/dd/yyyy / hh:mmN700

TIA8425:

O No

O Yes

mm/dd/yyyy / hh:mm713

Ischemic Stroke8430:

O No

O Yes

mm/dd/yyyy / hh:mm714

Hemorrhagic Stroke8435

O No

O Yes

mm/dd/yyyy / hh:mm715

Undetermined Stroke8440:

O No

O Yes

mm/dd/yyyy / hh:mm716

If TIA8425 or any Stroke Type8430/35/40 = Yes, (Select all that apply) CNS Event Territory N701:

□ Right Hemisphere or Retinal □ Left Hemisphere or Retinal □ Vertebrobasilar □ Unknown New Seizure8450:

O No

O Yes

mm/dd/yyyy / hh:mmN702

Intracranial Hemorrhage8455:

O No

O Yes

mm/dd/yyyy / hh:mmN703

O No

O Yes

mm/dd/yyyy / hh:mmN704

Thrombosis8475:(CAS Only)

O No

O Yes

mm/dd/yyyy / hh:mmN342

Embolism8480:

O No

O Yes

mm/dd/yyyy / hh:mmN343

Persistent Hypotension >24h Requiring Rx8415:

O No

O Yes

mm/dd/yyyy / hh:mm709

Anaphylactoid Contrast Reaction8525: (CAS Only)

O No

O Yes

mm/dd/yyyy / hh:mm739

Emergency CNS Rescue8460:

(CAS Only)

SYSTEMIC

(CAS Only)

VASCULAR Significant Dissection8485:

(CAS Only)

O No

O Yes

mm/dd/yyyy / hh:mm725

Perforation8490:

(CAS Only)

O No

O Yes

mm/dd/yyyy / hh:mm726

O No

O Yes

mm/dd/yyyy / hh:mm728

O No

O Yes

mm/dd/yyyy / hh:mm720

Procedure-Related Infection Req Antibiotics 8530:

O No

O Yes

mm/dd/yyyy / hh:mm745

Surgical Site Infection742

O No

O Yes

mm/dd/yyyy / hh:mm743

Other Vascular Complication Req Treatment8500: GENITOURINARY AND GASTROINTESTINAL

New Requirement for Dialysis8465: INFECTION

If Yes, Surgical Site Infection Type

744

:

O Superficial O Deep O Organ Space

Page 7 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT M. INTRA OR POST-PROCEDURE EVENTS (CONTINUED)

Event

Event Occurred

Event Date(s)

BLEEDING Bleeding Event w/in 72 Hours8535:

O No

O Yes

mm/dd/yyyy / hh:mmN344

O No

O Yes

mm/dd/yyyy / hh:mmN345

O No

O Yes

mm/dd/yyyy / hh:mmN346

 If Yes, Retroperitoneal Bleeding 8560:

O No

O Yes

mm/dd/yyyy / hh:mmN347

 If Yes, GI Bleed 8565:

O No

O Yes

mm/dd/yyyy / hh:mmN348

 If Yes, GU Bleed8570:

O No

O Yes

mm/dd/yyyy / hh:mmN349

 If Yes, Other Bleed8575:

O No

O Yes

mm/dd/yyyy / hh:mmN350

O No

O Yes

mm/dd/yyyy / hh:mm746

 If Yes, Bleeding at Access Site8540: (CAS Only)  If Yes, Access Bleed Location8545: Use Access Site ID / Seq. Num 6200:

______ , ______ , ______  If Yes, Hematoma at Access Site 8550: (CAS Only)  If Yes, Access Hematoma Location8555:

(CAS Only)

Use Access Site ID / Seq. Num 6200:

______ , ______ , ______

RBC/Whole Blood Transfusion8580:

 If Yes, Hgb Prior to 1st Transfusion 8585: ________ mg/dL  If Yes, Number of units Transfused 747: ________ units

N. DISCHARGE (COMPLETE FOR EACH EPISODE OF CARE) Discharge Date9000:

mm / dd / yyyy HH:MM

Discharging Provider Name, NPI 10070,10071,10072,10073: Discharge Status 9005: O Alive

________,__,__________________,______________

O Deceased

 If Alive, Discharge Location9010:

O Home O Extended Care/TCU/rehab

 If Alive, Hospice Care 9015:

O No

 If Deceased, Death during Procedure9025: O No

O O O O O O O

O No

O Yes

O Yes

9030

:

Acute myocardial infarction Sudden cardiac death Heart failure Stroke Cardiovascular procedure Cardiovascular hemorrhage Other cardiovascular reason

Discharge Ambulation Status907:

O Other O Left AMA

O Yes

 If Alive and Current Tobacco User, Cessation Counseling9020:

 If Deceased, Cause of Death

O Transfer to other acute care hospital O Skilled Nursing Facility

O O O O O O O

Pulmonary Renal Gastrointestinal Hepatobiliary Pancreatic Infection Inflammatory/Immunologic

O O O O O O O

Hemorrhage Non-cardiovascular procedure or surgery Trauma Suicide Neurological Malignancy Other non-cardiovascular reason

O No functional limitations O Ambulates with assistive devices

O Wheelchair/stretcher bound

Page 8 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT N. DISCHARGE (COMPLETE FOR EACH EPISODE OF CARE)

DISCHARGE MEDICATIONS Discharge medications are not required for patients who expired, discharged to “Other acute care Hospital,” “AMA”, or are receiving Hospice Care.

 If Yes, Dose908 Low Moderate High

 IF NO - PT. REASON, PATIENT RATIONALE14206

O

Direct Thrombin Inhibitor (Other)

O

O

O

O

Apixaban

O

O

O

O

Rivaroxaban

O

O

O

O

Direct Factor Xa Inhibitor (Other)

O

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

Warfarin

O

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

Aspirin

O

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

Dipyridamole

O

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

Clopidogrel

O

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

Prasugrel

O

O

O

O

Ticagrelor

O

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

P2Y12 Antagonist (Other)

O

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

ACE-I

ACE-I (Any)

O

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

ARB

ARB (Any)

O

O

O

O

Beta Blocke r

Beta Blocker (Any)

O

O

O

O

Sta tin

Statin (Any)

O

O

O

O

PDE Inhibitor

PDE Inhibitor (Any)

O

O

O

O

Alirocumab

O

O

O

O

Evolocumab

O

O

O

O

PCSK9 Inhibitors (Any)

O

O

O

O

P2Y12 Antagonists

Antiplatelets

Anticoagulants

Thrombin Inhibitors

□ Cost □ Negative Side Effect

Dabigatran

Direct Factor Xa Inhibitors

Yes

Prescribed at Discharge9505 No – No No – Medical No-Patient Reason Reason Reason O O O

VitK Ant

Medication9500

PCSK9 Inhibitor

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect □ Alternative Therapy Preferred □ Cost □ Negative Side Effect □ Alternative Therapy Preferred □ Cost □ Negative Side Effect

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect □ Alternative Therapy Preferred □ Cost □ Negative Side Effect

O

O

O

□ Alternative Therapy Preferred □ Cost □ Negative Side Effect □ Alternative Therapy Preferred □ Cost □ Negative Side Effect □ Alternative Therapy Preferred □ Cost □ Negative Side Effect □ Alternative Therapy Preferred □ Cost □ Negative Side Effect □ Alternative Therapy Preferred

Discharge Medication Reconciliation Completed 14020:  If Yes, Medications Reconciled Include:



Non Prescription (OTC) Medications

14025

O No

(Select all that apply)



O Yes



Vitamins / Minerals

Prescriptions: Cardiac



□ Prescription: Non Cardiac

Herbal Supplements

Page 9 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT O. FOLLOW-UP (30 DAYS POST INDEX PROCEDURE: +/- 7 DAYS AND 1 YEAR POST INDEX PROCEDURE: +/- 60 DAYS)

Assessment Date10000:

Reference Episode Arrival Date/Time xxxx:

mm / dd / yyyy

mm/dd/yyyy / hh:mm

Reference Procedure Start Date/Time10001/10002: mm/dd/yyyy / hh:mm Reference Episode Discharge Date/Time xxxx: mm/dd/yyyy / hh:mm Method(s) to Determine Status10005-11: (Select all that apply)

Follow-up Status10015: O Alive

□ Office Visit □ Medical Records □ Letter from Medical Provider □ Phone Call □ Social Security Death Master File □ Hospitalized □Other

O Deceased

O Lost to Follow-up

 If Deceased, Date of Death10020: mm / dd / yyyy  If Deceased, Cause of Death10025: O O O O O O O

Acute myocardial infarction Sudden cardiac death Heart failure Stroke Cardiovascular procedure Cardiovascular hemorrhage Other cardiovascular reason

O O O O O O O

Pulmonary Renal Gastrointestinal Hepatobiliary Pancreatic Infection Inflammatory/Immunologic

O O O O O O O

Hemorrhage Non-cardiovascular procedure or surgery Trauma Suicide Neurological Malignancy Other non-cardiovascular reason

CLINICAL ASSESSMENT AT FOLLOW-UP (30 DAYS POST INDEX PROCEDURE: +/- 7 DAYS AND 1 YEAR POST INDEX PROCEDURE: +/- 60 DAYS) Follow-Up Ambulation Status913:

O No functional limitations O Ambulates with assistive devices

Follow-Up Living Status914:

O Home Independent O Home with Caregiver O Skilled Nursing Facility O Homeless O Other

Follow-Up CSHA Clinical Frailty Score 1 915:

O 1 = Very Fit O 2 = Well O 3 = Managing Well O 4 = Vulnerable O 5 = Mildly Frail

Modified Rankin Score10030:

Date Administered10031:

O 6 = Moderately Frail O 7 = Severely Frail O 8 = Very Severely Frail O 9 = Terminally Ill

O 0: No symptoms at all O 4: Mod severe disability O 1: No sig disability despite symptoms O 5: Severe disability O 2: Slight disability O 6: Death O 3: Moderate disability □ Not Administered 10032 mm / dd / yyyy

NIH Stroke Scale Total Score 10035: _______ Date Administered10036:

O Wheelchair/stretcher bound

mm / dd / yyyy

Examiner Name 10040, 10045, 10050:

□ Not Administered 10037

Certified Examiner 10055:

O No

Right O No

Follow-Up Carotid Duplex Ultrasound Performed N705, N709:  If Yes, Peak Systolic VelocityN706, N710: N707, N711

 If Yes, End Diastolic Velocity

 If Yes, ICA/CCA Ration N708, N712:

:

O Yes

O Yes

Left O No

O Yes

_________cm/sec

_________cm/sec

_________cm/sec

_________cm/sec

_________

_________

1

Canadian Study of Health and Aging Clinical Frailty Scale is Used with Permission For The American College of Cardiology Foundation By Dr. Kenneth Rockwood (© Kenneth Rockwood, MD)

Page 10 of 11

NCDR® PVI Registry™(Peripheral Vascular Intervention Registry) v 2 Carotid Artery Stenting, Carotid Endarterectomy and Carotid PTA Module- DRAFT O. FOLLOW-UP (CONTINUED)

EVENTS SINCE DISCHARGE Readmitted10400:

 If Yes, Readmission Related to procedure N367 :  If Yes, Readmission Length of Stay : _____ days O No

O Yes

O No

O Yes

O Indeterminate

10405

 If Yes, Readmission Date 10410:

mm / dd / yyyy

 If Yes, Hospitalized at time of Follow-up10415:

Event

O No

O Yes

Event Occurred

Event Date(s)

CARDIOVASCULAR Myocardial Infarction 10420:

O No

O Yes

mm / dd / yyyy933

Ischemic Stroke 10425:

O No

O Yes

mm / dd / yyyy934

Hemorrhagic Stroke10430:

O No

O Yes

mm / dd / yyyy935

Undetermined Stroke10435:

O No

O Yes

mm / dd / yyyy936

Carotid Endarterectomy10470: (CEA only)

O No

O Yes

mm / dd / yyyyN715

O No

O Yes

mm / dd / yyyyN716

O No

O Yes

mm / dd / yyyyN720

O No

O Yes

mm / dd / yyyyN721

O No

O Yes

mm / dd / yyyyN723

O No

O Yes

mm / dd / yyyyN725

O No

O Yes

mm / dd / yyyy937

O No

O Yes

mm / dd / yyyy944

O No

O Yes

mm / dd / yyyy938

NEUROLOGIC

 If Yes, Target Vessel Revascularization 10475 Carotid Artery Stent10480: (CAS only)  If Yes, Target Vessel Revascularization10485 Carotid PTA N722:  If Yes, Target Vessel RevascularizationN724 VASCULAR Major Vascular Complication 10440: GENITOURINARY AND GASTROINTESTINAL

New Requirement for Dialysis10450: BLEEDING Life Threatening Bleeding10445:

Page 11 of 11